Klingel medical metal group (Klingel), owned by the IK Partners’ funds, is to acquire Ruetschi Technology Holding AG (Ruetschi), a contract manufacturer for medical devices, with a special focus on sterile packaged single-use procedure kits for orthopaedic, spinal and dental surgery.
This transaction represents the fourth acquisition for Klingel since IK Partners (IK) acquired a majority stake in 2018.
Ruetschi was founded in 1960 and employs more than 200 people at three production sites in Muntelier (CH), Yverdon (CH) and Renquishausen (DE). Like Klingel, Ruetschi is a leading one-stop-shop with profound expertise in engineering, product innovation and development as well as regulatory requirements. It operates a state-of-the-art machine park and serves a number of top MedTech OEM customers.
Through the acquisition, Klingel further strengthens its leading position as MedTech CMO in Europe and a key partner for its global customer base with highest quality requirements.
Ralf Petrawitz, CEO of Klingel, says: “Ruetschi is the perfect complement for our growing MedTech platform in Europe. The combination does not only add further manufacturing capabilities to Klingel’s offering, but also brings leading MedTech customers to the group. We look forward to continuing the journey and grow stronger and larger together with Ruetschi.”
Christoph Ruetschi, CEO of Ruetschi, says: “We are very happy to have found a good partner with Klingel to form a clear leader in our field. Klingel is the perfect home for our 200 employees and will enable the company to thrive as part of a European group. Together we will be able to serve our customers even better by offering a broader set of services.”
